{"Symbol": "GNCA", "AssetType": "Common Stock", "Name": "Genocea Biosciences, Inc", "Description": "Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, to profile patient's CD4+ and CD8+ T cell immune responses to potential target or antigen in that patient's tumor. It develops immuno-oncology programs, such as GEN-009, an adjuvanted neoantigen peptide vaccine candidate, which is in the phase I/IIa clinical trial; GEN-011, a neoantigen adoptive T cell therapy program; and GEN-010, a neoantigen vaccine program. Genocea Biosciences, Inc. was founded in 2006 and is based in Cambridge, Massachusetts.", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "Healthcare", "Industry": "Biotechnology", "Address": "100 Acorn Park Drive, Cambridge, MA, United States, 02140", "FullTimeEmployees": "59", "FiscalYearEnd": "December", "LatestQuarter": "2020-06-30", "MarketCapitalization": "119144528", "EBITDA": "-38193000", "PERatio": "None", "PEGRatio": "0", "BookValue": "0.245", "DividendPerShare": "None", "DividendYield": "0", "EPS": "-2.376", "RevenuePerShareTTM": "0.032", "ProfitMargin": "0", "OperatingMarginTTM": "-48.5453", "ReturnOnAssetsTTM": "-0.4941", "ReturnOnEquityTTM": "-1.7671", "RevenueTTM": "906000", "GrossProfitTTM": "-26952000", "DilutedEPSTTM": "-1.469", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "0", "AnalystTargetPrice": "9.4", "TrailingPE": "0", "ForwardPE": "0", "PriceToSalesRatioTTM": "69.0976", "PriceToBookRatio": "15.681", "EVToRevenue": "130.3323", "EVToEBITDA": "0", "Beta": "2.3896", "52WeekHigh": "5.75", "52WeekLow": "1.1", "50DayMovingAverage": "2.8932", "200DayMovingAverage": "2.3326", "SharesOutstanding": "51355400", "SharesFloat": "19175480", "SharesShort": "231511", "SharesShortPriorMonth": "88358", "ShortRatio": "1.06", "ShortPercentOutstanding": "0.05", "ShortPercentFloat": "0.0593", "PercentInsiders": "12.78", "PercentInstitutions": "55.233", "ForwardAnnualDividendRate": "0", "ForwardAnnualDividendYield": "0", "PayoutRatio": "0", "DividendDate": "None", "ExDividendDate": "None", "LastSplitFactor": "1:8", "LastSplitDate": "2019-05-22"}